等待开盘 04-02 09:30:00 美东时间
-0.110
-1.86%
今日重点评级关注:RBC Capital:维持4D Molecular Therapeutics"跑赢大市"评级,目标价从32美元升至35美元;巴克莱:维持CytomX医疗"超配"评级,目标价从10美元升至16美元
03-20 15:53
Keefe, Bruyette & Woods analyst Tommy McJoynt maintains MBIA (NYSE:MBI) with a Outperform and lowers the price target from $8.5 to $7.5.
03-20 00:47
Companies Reporting Before The Bell • Enovis (NYSE:ENOV) is estimated to report...
02-26 19:11
MBIA Incorporated published an update to their financial calendar - **Full year and fourth quarter 2025 results release:** MBIA Inc. will make its financial results report and 10-K filing available after the market closes on **Thursday, February 26, 2026**, and will post them on https://www.mbia.com
02-21 00:15
今日重点评级关注:富国银行:维持Annexon"超配"评级,目标价从14美元升至27美元;瑞穗:上调Relmada Therapeutics评级至"跑赢大市",目标价从1美元升至10美元
2025-11-20 10:28
Keefe, Bruyette & Woods analyst Thomas McJoynt-Griffith maintains MBIA (NYSE:MBI) with a Outperform and raises the price target from $8 to $8.5.
2025-11-19 22:40
MBIA Inc : KBW Raises Target Price to $8.5 From $8
2025-11-19 14:38
MBIA Incorporated announced the availability of its third quarter 2025 financial results in a Current Report on Form 8-K. The report is posted at https://investor.mbia.com/investor-relations/financial...
2025-11-05 05:19
MBIA (NYSE:MBI) reported quarterly earnings of $1.03 per share which beat the analyst consensus estimate of $(0.10) by 1080.95 percent. The company reported quarterly sales of $15.000 million which beat the analyst
2025-11-05 05:18
(来源:金科之家网) 一、早年岁月 1988 年,22 岁的比尔・阿克曼在哈佛大学完成的毕业论文,埋下了他一生 “质疑惯性” 的种子。 这篇题为《攀登常...
2025-10-23 05:00